1. Home
  2. AVXL vs EVH Comparison

AVXL vs EVH Comparison

Compare AVXL & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.40

Market Cap

289.1M

Sector

Health Care

ML Signal

HOLD

Logo Evolent Health Inc

EVH

Evolent Health Inc

HOLD

Current Price

$2.99

Market Cap

272.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVXL
EVH
Founded
2004
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
289.1M
272.4M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
AVXL
EVH
Price
$3.40
$2.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
15
Target Price
$22.00
$7.93
AVG Volume (30 Days)
2.0M
3.0M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$907,957,000.00
Revenue This Year
N/A
$33.89
Revenue Next Year
N/A
$15.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.61
$2.10
52 Week High
$13.99
$11.92

Technical Indicators

Market Signals
Indicator
AVXL
EVH
Relative Strength Index (RSI) 47.74 60.61
Support Level $2.93 $2.53
Resistance Level $4.88 $4.20
Average True Range (ATR) 0.18 0.21
MACD 0.06 0.09
Stochastic Oscillator 98.62 92.63

Price Performance

Historical Comparison
AVXL
EVH

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.

Share on Social Networks: